Peter Osin

4.5k citations

39 papers · 2.8k indexed · 3 hit papers · h-index 15

Impact in

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Oncology top 2%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research

Papers in ⓘ

Cancer Research 23
- Breast Cancer Treatment Studies 15
- Cancer Genomics and Diagnostics 9
Pathology and Forensic Medicine 18
- Breast Lesions and Carcinomas 13
- Genetic factors in colorectal cancer 5

Co-authors: Ashutosh Nerurkar (24 shared papers)Ian E. Smith (10 shared papers)Mitch Dowsett (10 shared papers)Nicholas C. Turner (10 shared papers)Gaia Schiavon (6 shared papers)Isaac García-Murillas (6 shared papers)Sunil R. Lakhani (3 shared papers)Marc J. van de Vijver (1 shared paper)
Journals: Breast Cancer Research (4 papers)Journal of Clinical Oncology (4 papers)Breast Cancer Research and Treatment (4 papers)European Journal of Surgical Oncology (3 papers)Cancer Research (3 papers)
Partner nations: United Kingdom United States Canada

In The Last Decade

Peter Osin

39 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer 2015 · 814 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Science Translational Medicine
2015 Science Translational Medicine
2002 Journal of Clinical Oncology

Peers

Countries citing papers authored by Peter Osin

Since Specialization

Citations

This map shows the geographic impact of Peter Osin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Osin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Osin more than expected).

Fields of papers citing papers by Peter Osin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Osin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Osin. The network helps show where Peter Osin may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Osin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Osin Line = papers co-authored together Peter Osin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer Science Translational Medicine ·Isaac García-Murillas, Gaia Schiavon, Britta Weigelt, Charlotte K.Y. Ng, Sarah Hrebien, Rosalind Cutts, Maggie C.U. Cheang, Peter Osin, Ashutosh Nerurkar, Iwanka Kozarewa, Javier Armisen Garrido, Mitch Dowsett, Jorge S. Reis‐Filho, Ian E. Smith, Nicholas C. Turner Hit paper breakdown →	2015	814
2	The Pathology of Familial Breast Cancer: Predictive Value of Immunohistochemical Markers Estrogen Receptor, Progesterone Receptor, HER-2, and p53 in Patients With Mutations in BRCA1 and BRCA2 Journal of Clinical Oncology ·Sunil R. Lakhani, Marc J. van de Vijver, Jocelyne Jacquemier, Thomas Anderson, Peter Osin, Lesley McGuffog, Douglas F. Easton Hit paper breakdown →	2002	614
3	Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer Science Translational Medicine ·Gaia Schiavon, Sarah Hrebien, Isaac García-Murillas, Rosalind Cutts, Alex Pearson, Noelia Tarazona, Kerry Fenwick, Iwanka Kozarewa, Elena López‐Knowles, Ricardo Ribas, Ashutosh Nerurkar, Peter Osin, Sarat Chandarlapaty, Lesley‐Ann Martin, Mitch Dowsett, Ian E. Smith, Nicholas C. Turner Hit paper breakdown →	2015	416
4	Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC) Annals of Oncology ·Mónica Arnedos, Ashutosh Nerurkar, Peter Osin, Roger A’Hern, Ian E. Smith, Mitch Dowsett	2009	142
5	Noninvasive Detection of HER2 Amplification with Plasma DNA Digital PCR Clinical Cancer Research ·Heidrun Gevensleben, Isaac García-Murillas, Monika Graeser, Gaia Schiavon, Peter Osin, Marina Parton, Ian E. Smith, Alan Ashworth, Nicholas C. Turner	2013	135
6	Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer Breast Cancer Research ·Isabel Pinhel, Fiona MacNeill, Margaret J. Hills, Janine Salter, Simone Detre, Roger A’Hern, Ashutosh Nerurkar, Peter Osin, Ian E. Smith, Mitch Dowsett	2010	103
7	Molecular Profiling of Aromatase Inhibitor–Treated Postmenopausal Breast Tumors Identifies Immune-Related Correlates of Resistance Clinical Cancer Research ·Anita K. Dunbier, Zara Ghazoui, H Anderson, Janine Salter, Ashutosh Nerurkar, Peter Osin, Roger A’Hern, William R. Miller, Ian E. Smith, Mitch Dowsett	2013	98
8	Relationship Between Plasma Estradiol Levels and Estrogen-Responsive Gene Expression in Estrogen Receptor–Positive Breast Cancer in Postmenopausal Women Journal of Clinical Oncology ·Anita K. Dunbier, H Anderson, Zara Ghazoui, Elizabeth Folkerd, Roger A’Hern, Robert J. Crowder, Jeremy Hoog, Ian E. Smith, Peter Osin, Ashutosh Nerurkar, Joel S. Parker, Charles M. Perou, Matthew J. Ellis, Mitch Dowsett	2010	91
9	Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions Oncogene ·Paul Smith, Susan Crossland, Gillian A. Parker, Peter Osin, Louise Brooks, Joanne Waller, Elizabeth Philp, M. Rufus Crompton, Barry A. Gusterson, Martin J. Allday, Tim Crook	1999	84
10	Concomitant inactivation of p53 and Chk2 in breast cancer Oncogene ·Alexandra Sullivan, Martin Yuille, Claire E. Repellin, Archana Reddy, Olivier Reelfs, Alexandra Bell, Barbara Dunne, Barry A. Gusterson, Peter Osin, Paul J. Farrell, Işık G. Yuluğ, Abigail Evans, Tayfun Özçelık, Milena Gasco, Tim Crook	2002	67
11	Gene promoter hypermethylation in ductal lavage fluid from healthy BRCAgene mutation carriers and mutation-negative controls Breast Cancer Research ·Imogen Locke, Zsofia Kote‐Jarai, Mary Jo Fackler, Elizabeth Bancroft, Peter Osin, Ashutosh Nerurkar, Louise Izatt, Gabriella Pichert, Gerald Gui, Rosalind A. Eeles	2007	32
12	The inframammary fold: contents, clinical significance and implications for immediate breast reconstruction British Journal of Plastic Surgery ·Gerald Gui, Kasim A. Behranwala, N Abdullah, Jason Seet, Peter Osin, Ashutosh Nerurkar, Sunil R. Lakhani	2004	23
13	Experimental Pathology and Breast Cancer Genetics: New Technologies Recent results in cancer research ·Peter Osin, Janet Shipley, Yong‐Jie Lu, Tim Crook, B.A. Gusterson	1998	19
14	Breast development gives insights into breast disease Histopathology ·Peter Osin, Rajakumar Anbazhagan, Jiřina Bártková, B. Nathan, B.A. Gusterson	1998	17
15	DNA promoter hypermethylation profiles in breast duct fluid Breast Cancer Research and Treatment ·Dominique Twelves, Ashutosh Nerurkar, Peter Osin, Tim Dexter, Ann Ward, Gerald Gui, Clare M. Isacke	2013	15
16	Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer European Journal of Surgical Oncology ·Gerald Gui, D.J. Joubert, R. Reichert, Ann Ward, Sunil R. Lakhani, Peter Osin, Ashutash Nerurkar, Roger A’Hern, Keith G. Benson, S. R. Underwood	2005	14
17	Metastatic adenocarcinoma in a thyroid colloid nodule: A rare presentation of colon cancer Pathology ·Peter Osin, Eitan Shiloni, Alon J. Pikarsky, E. Okon	1996	13
18	Testing the Feasibility of Intra-Operative Sentinel Lymph Node Touch Imprint Cytology Annals of The Royal College of Surgeons of England ·Alireza Hamidian Jahromi, Sankaran Narayanan, Fiona MacNeill, Peter Osin, Ashutash Nerurkar, Gerald Gui	2009	13
19	The feasibility of nipple aspiration and duct lavage to evaluate the breast duct epithelium of women with increased breast cancer risk European Journal of Cancer ·Dominique Twelves, Ashutosh Nerurkar, Peter Osin, Ann Ward, Clare M. Isacke, Gerald Gui	2012	11
20	The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years European Journal of Surgical Oncology ·Steven Allen, Peter Osin, Ashutash Nerurkar	2014	11

About Peter Osin

Peter Osin is a scholar working on Cancer Research, Pathology and Forensic Medicine, Oncology, Molecular Biology and Genetics, having authored 39 papers that have together received 2.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (15 papers), Breast Lesions and Carcinomas (13 papers), Cancer Genomics and Diagnostics (9 papers), BRCA gene mutations in cancer (6 papers), Genetic factors in colorectal cancer (5 papers), Cancer Cells and Metastasis (5 papers), Breast Implant and Reconstruction (5 papers) and Cancer and Skin Lesions (5 papers). The work is most often cited by research in Cancer Research (1.8k citations), Oncology (1.3k citations), Pathology and Forensic Medicine (571 citations), Genetics (802 citations) and Pulmonary and Respiratory Medicine (735 citations). Peter Osin has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Ashutosh Nerurkar, Ian E. Smith, Mitch Dowsett, Nicholas C. Turner, Gaia Schiavon, Isaac García-Murillas, Sunil R. Lakhani, Marc J. van de Vijver, Thomas Anderson and Douglas F. Easton. Their work appears in journals such as Breast Cancer Research, Journal of Clinical Oncology, Breast Cancer Research and Treatment, European Journal of Surgical Oncology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact